New product intros [anlotinib dihydrochloride, brexanolone, dexamethasone punctum plug (new formulation), dupilumab (new indication), eculizumab (new indication), halobetasol propionate/tazarotene (new combination), selinexor]

2019 ◽  
Vol 55 (7) ◽  
pp. 477
Sign in / Sign up

Export Citation Format

Share Document